Indian firms may garner up to 50% of USFDA nod share in 2023
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
©2024 Blitz India Media -Building A New Nation
Tag: USFDA
Sun Pharma recalls over 24K prefilled syringes of generic medication in the US
Team Blitz India NEW DELHI: Drug major Sun Pharmaceutical Industries is recalling pre-filled syringes of a drug, used to treat ...
Recent News
India secures third straight term as head of Solar Alliance
NEW DELHI, 4 November: India has been elected President of the International Solar Alliance for a third consecutive term. This...
Read moreDetails